Filter Results :

Your search for Antibodies returned 55 reports

Sort by


Advanced and Targeted Drug Delivery Market Segmentation, Analysis & Forecast to 2021 - Nanoparticles, Polymers, Liposomes, Micelles, Nanoemulsions, Dendrimers, Monoclonal Antibodies by Geography, Therapeutic Area and Stakeholder Environment

04 Apr 2016  |  Published by:  Kelly Scientific Publications
Advanced and Targeted Drug Delivery Market Segmentation, Analysis & Forecast to 2021 Nanoparticles, Polymers, Liposomes, Micelles, Nanoemulsions, Dendrimers, Monoclonal Antibodies by Geography, Therapeutic Area and Stakeholder Environment This newly published report is a global industry ...

$ 4,307.68

Read More

Global Anti-CD20 Monoclonal Antibodies Industry 2016 Market Research Report

18 Mar 2016  |  Published by:  9Dimen Research
2016 Global Anti-CD20 Monoclonal Antibodies Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Anti-CD20 Monoclonal Antibodies industry, focusing on the main regions (North America, Europe and Asia) and the main count...

$ 2,850.00

Read More

Competitor Analysis: Dengue Virus Vaccines, Antibodies & Antivirals

01 Feb 2016  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence Report provides a competitor evaluation in the field of approved and investigational vaccines and therapeutics against one or more serotypes of Dengue Virus for prophylaxis or treatment of Dengue fever as of February 2016. The report covers live attenuated or whol...

$ 226.72

Read More

Engineered Bispecific Antibodies (BsAb) Novel Approaches & Pipeline Insights, 2016

01 Jan 2016  |  Published by:  DelveInsight
Summary “Engineered Bispecific Antibodies (BsAb) Novel Approaches & Pipeline Insights, 2016” emphasizes on the novel bispecific antibodies technologies in research and development. The report enlists company, target antigens, phase and indication specific R&D pipelines of Bispecifc ...

$ 2,750.00

Read More

Immunotherapy Drugs Market by Type of Drug (Monoclonal Antibodies, Interferon-Alpha, Interleukins, Vaccines, (Therapeutic Vaccines and Preventive Vaccines), Checkpoint Inhibitors), Epidemiology, Regulatory and Pipeline Analysis - Global Forecast to 2020

01 Dec 2015  |  Published by:  MarketsandMarkets
The immunotherapy drugs market is broadly segmented on the basis of type of drugs and geographic region. The major type of immunotherapy drugs studied in the report includes antibodies (monoclonal and polyclonal), interferon (alpha), interleukins, vaccines, and checkpoint inhibitors. Among these typ...

$ 4,650.00

Read More

Competitor Analysis: Amyloid beta- and Tau-Targeted Antibodies & Vaccines

26 Sep 2015  |  Published by:  La Merie Business Intelligence
The Competitive Intelligence Report Amyloid beta- and Tau-Targeted Antibodies & Vaccines as of September 2015 provides a competitor analysis in the  development pipeline of novel antibodies and vaccines for passive and active  immunotherapy of Alzheimer's disease or progressive supranu...

$ 340.08

Read More

Global Antibodies Industry 2015 Market Research Report

13 Aug 2015  |  Published by:  QYResearch
The Global Antibodies Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Antibodies industry.The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Antibodies market...

$ 2,800.00

Read More

Global Biosimilar Monoclonal Antibodies Industry 2015 Market Research Report

13 Aug 2015  |  Published by:  QYResearch
The Global Biosimilar Monoclonal Antibodies Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Biosimilar Monoclonal Antibodies industry.The report provides a basic overview of the industry including definitions, classifications, applications and in...

$ 2,800.00

Read More

Global & USA BioSimilar Market Analysis to 2021; BioBetters, Erythropoietin (EPO), Human Growth Hormone (HGH), Granulocyte Colony-Stimulating Factor (G-CSF), Anti-Tumor Necrosis Factor (Anti-TNF), Monoclonal Antibodies (MAbs), Insulins, Interferons, Product Pipelines, Trends, Key Players, Regulations and Strategic Outlook

01 Aug 2015  |  Published by:  Kelly Scientific Publications
Biosimilars are highly-similar versions of biological drugs that are indicated for cancer, kidney disorders and a wide range of autoimmune diseases. Originator biologics are the most expensive drugs in the pharmaceutical industry and many of them cost nearly $100,000 per patient per year. Thes...

$ 3,400.00

Read More

Global Monoclonal Antibodies Industry 2015 Market Research Report

17 Jul 2015  |  Published by:  9Dimen Research
2015 Global Monoclonal Antibodies Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Monoclonal Antibodies industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan ...

$ 2,850.00

Read More

Biosimilars Market by Product (Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Interferons, rHGH), Glycosylated (Monoclonal Antibodies, EPO), Peptides (Glucagon, Calcitonin)) & Application (Oncology, Blood Disorders) - Global Forecast to 2020

16 Jul 2015  |  Published by:  MarketsandMarkets
Report Description Various factors have contributed to the rise in demand for biopharmaceutical products such as biologics and biosimilars. Some of these factors include the rising pressure to reduce healthcare expenditure, growing demand for cost-effective alternatives, growing burden of c...

$ 4,650.00

Read More

Global Breast Cancer Monoclonal Antibodies Market Outlook 2020

22 May 2015  |  Published by:  KuicK Research
Breast cancer incidences are increasing across the globe and conventional therapeutics have modest pharmacological efficacy. To surmount this issue, investigators came forth with monoclonal antibodies for breast cancer treatment which have targeted capabilities along with higher safety and eff...

$ 1,800.00

Read More

Competitor Analysis: Therapeutic Antibodies 2015 - Biosimilars & Biosuperiors

01 Apr 2015  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence Report about Therapeutic Antibodies 2015: Biosimilars & Biosuperiors provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies in the market, in the pipeline as next generation products and as biosimilar versions as of A...

$ 1,473.68

Read More

The 2016 Report on AntiCD20 Monoclonal Antibodies: World Market Segmentation by City

01 Apr 2015  |  Published by:  Icon Group International, Inc
This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a “borderless world”, cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report cov...

$ 995.00

Read More

Competitor Analysis: EGF-R Antibodies 2015 - Biosuperiors and Biosimilars of Erbitux

28 Mar 2015  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence Report about EGF-R Antibodies 2015 – Biosuperiors and Biosimilars of Erbitux provides a competitor evaluation in the field of recombinant antibodies targeting epithelial growth factor receptor (EGF-R) to treat solid tumors as of March 2015. Purchase of the downloa...

$ 283.40

Read More
Total 55 records.